Stay updated on Immunotherapy in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy in NSCLC Clinical Trial page.

Latest updates to the Immunotherapy in NSCLC Clinical Trial page
- Check4 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing v3.5.3. This reflects a small backend/UI update to the study record page.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedTaoyuan District, Taiwan was removed and Taoyuan, Taiwan was added in the study's Taiwan locations list.SummaryDifference0.0%

- Check26 days agoChange DetectedThe page’s footer revision/version indicator has been updated from v3.5.0 to v3.5.3.SummaryDifference0.0%

- Check62 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check76 days agoChange DetectedRevision: v3.4.3 is now displayed, replacing Revision: v3.4.2.SummaryDifference0.0%

- Check98 days agoChange DetectedPage revision updated from v3.4.1 to v3.4.2; no user-visible changes to study details, eligibility criteria, locations, or timelines.SummaryDifference0.0%

Stay in the know with updates to Immunotherapy in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy in NSCLC Clinical Trial page.